Other
SCAT-5
SCAT-5 is an intervention with 4 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
2(50%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(2)
Detailed Status
Completed2
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
4
Active
2
Success Rate
100.0%
Trials by Status
completed250%
active_not_recruiting250%
Recent Activity
2 active trials
Showing 4 of 4
active_not_recruiting
HITT for the Identification of Mild Traumatic Brain Injury
NCT05092282
active_not_recruiting
Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury
NCT05092295
completed
SSVEP Evaluation of Brain Function
NCT05614570
completed
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
NCT04074486
Clinical Trials (4)
Showing 4 of 4 trials
NCT05092282
HITT for the Identification of Mild Traumatic Brain Injury
NCT05092295
Head and Intraocular Trauma Tool for the Identification of Mild Traumatic Brain Injury
NCT05614570
SSVEP Evaluation of Brain Function
NCT04074486
Evaluation and Validation of a Multimodal Brain Function Biomarker With NPC
All 4 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 4